Improving Heart Function (iHF)
@iheartfunction
Followers
100
Following
38
Media
32
Statuses
104
Advancing trans-disciplinary innovation in #heartfailure drugs and device solutions to improve patient care. #ImprovingHeartFunction
Joined January 2025
RT @EJHFEiC: 🗞️ Prognostic value of #NT_proBNP in patients with primary mitral regurgitation undergoing transcatheter edge-to-edge repair….
0
16
0
Can dapagliflozin improve function & QoL in patients with systemic right ventricular HF?. This latest piece explores the potential of #SGLT2 inhibitors in a tough-to-treat group. Read more👉 #ImprovingHeartFunction #CardioEd
0
1
2
🆕 New Journal Club! @Jolie_Bruno_ & @AlexMebazaa Mebazaa break down the CONFIDENCE trial (published in the @NEJM):.💊 Finerenone + Empagliflozin in CKD + T2D. 📖Study insights & results here👉
0
5
22
🚫Therapeutic impasse? Not anymore. Refractory heart failure is becoming a catalyst for change — in strategy, in collaboration, and in outcomes. 🔍 @EmanueleBarba13 & @AlexMebazaa dive into the power of combining pharmacological advances with device-based therapies in a
3
4
6
RT @DavidDuncker: Ich habe den Ruf auf die W2-Professur Rhythmologie und Elektrophysiologie an der Medizinischen Hochschule Hannover angeno….
0
4
0
RT @ARakisheva: The webinar on novel fast-track strategies to guidelines-directed medical therapy optimisation in heart failure patients wi….
0
1
0
⌛Happening this Thursday, 19 June at 18:00 CET!. A new #ImprovingHeartFunction webinar on fast-track #GDMT optimisation in HF patients with functional MR. Join Emanuele Barbato, @GMCRosano, @PhilippLurz and @AlexMebazaa for a live discussion. Free
0
2
4
RT @GMCRosano: @iheartfunction @PhilippLurz @AlexMebazaa Join us! #improvingheartfunction is key to transdisciplinary management of #heartf….
0
1
0
⌛Happening this Thursday, 19 June at 18:00 CET!. A new #ImprovingHeartFunction webinar on fast-track #GDMT optimisation in HF patients with functional MR. Join Emanuele Barbato, @GMCRosano, @PhilippLurz and @AlexMebazaa for a live discussion. Free
2
2
9
RT @GMCRosano: Don't miss this webinar - we'll see you online at 6pm today for a transdisciplinary discussion about #GDMT optimisation in #….
0
2
0
New from #FINEARTS‑HF recently presented at #HeartFailure2025:.Finerenone reduced risk of CV death or HF events in patients with EF ≥40%. 📉 HR 0.87 | Median follow-up: 3 yrs.⚠️ More hypotension, but overall well tolerated. 💡 Adds to options in #HFmrEF / #HFpEF.More
0
0
2
RT @JuliaSellerm: Top3 heart failure trials in May 2025. 🥇Finerenone in HF with improved EF @JAMA_current . 🥈Albuminuria as a diagnostic cr….
0
79
0
RT @EJHFEiC: Cardiac resynchronization therapy for enabling guideline-directed medical therapy optimization in heart failure. https://t.co/….
0
17
0
Wondering what #ImprovingHeartFunction (iHF) is all about?.The Daily Wire highlights iHF at #EuroPCR 2025, with a strong message: #heartfailure🫀needs a transdisciplinary response. Insights from the Steering Committee👉
0
1
2
🎥 #ICYMI: This #EuroPCR session with #ImprovingHeartFunction dives into the value of coordinated care in complex #HeartFailure cases. 👨⚕️ A 69-year-old with severe LV dysfunction & mitral regurgitation is at the heart of the discussion. @Pcronline.🔓 Watch free⬇️.
0
5
4
RT @EHRAPresident: 💥#EHRAtopicweek on SCD prevention in HF. 💡 Did you know? Optimizing GDMT doesn’t just improve symptoms — it saves lives….
0
29
0
RT @cardioceptor: Great debate: ablation of atrial fibrillation should be performed in patients with heart failure with reduced ejection fr….
0
5
0
Delayed initiation of lipid-lowering therapy in addition to statins after MI is associated with an increased risk of major CV events compared to early initiation, according to data from the SWEDEHEART registry published in JACC. 🔗
0
1
2
RT @GiuseppeGalati_: 🔥 Clinical & financial implications of inpatient & outpatient management of #WorseningHF. 🏥 Hospitalization .🚨 ER disc….
0
14
0